These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35343356)
1. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage. Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage. de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398 [TBL] [Abstract][Full Text] [Related]
4. Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves. Sakusic A; Rabinstein AA; Anisetti B; Mandrekar J; Wijdicks EFM; Freeman WD; Braksick SA Neurology; 2024 Aug; 103(4):e209664. PubMed ID: 39102615 [TBL] [Abstract][Full Text] [Related]
5. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding. Becattini C; Cimini LA; Carrier M Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872 [TBL] [Abstract][Full Text] [Related]
6. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. Rojas-Hernandez CM; Oo TH; García-Perdomo HA J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333 [TBL] [Abstract][Full Text] [Related]
7. Optimal Timing for Resumption of Anticoagulation After Intracranial Hemorrhage in Patients With Mechanical Heart Valves. Barra ME; Forman R; Long-Fazio B; Merkler AE; Gurol ME; Izzy S; Sharma R J Am Heart Assoc; 2024 May; 13(10):e032094. PubMed ID: 38761076 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review. Gorman J; Candeloro M; Schulman S Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Zwicker JI; Karp Leaf R; Carrier M J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689 [TBL] [Abstract][Full Text] [Related]
10. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study. Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405 [TBL] [Abstract][Full Text] [Related]
11. Management of intracranial hemorrhage in patients with left ventricular assist devices. Wilson TJ; Stetler WR; Al-Holou WN; Sullivan SE; Fletcher JJ J Neurosurg; 2013 May; 118(5):1063-8. PubMed ID: 23451903 [TBL] [Abstract][Full Text] [Related]
12. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases. Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956 [TBL] [Abstract][Full Text] [Related]
13. Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. Ma M; Meretoja A; Churilov L; Sharma GJ; Christensen S; Liu X; Weir L; Davis SM; Yan B J Neurol Sci; 2013 Sep; 332(1-2):75-9. PubMed ID: 23911098 [TBL] [Abstract][Full Text] [Related]
14. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants. Ip B; Pan S; Yuan Z; Hung T; Ko H; Leng X; Liu Y; Li S; Lee SY; Cheng C; Chan H; Mok V; Soo Y; Wu X; Lui LT; Chan R; Abrigo J; Dou Q; Seiffge D; Leung T JAMA Netw Open; 2024 Feb; 7(2):e2354916. PubMed ID: 38319661 [TBL] [Abstract][Full Text] [Related]
15. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage. Cicci CD; Weiss A; Dang C; Stanton M; Feldman R Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000 [TBL] [Abstract][Full Text] [Related]
16. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment of early therapeutic anticoagulation following cranial surgery: an institutional case series. Davison MA; Patel AA; Lilly DT; Shost MD; Kashkoush AI; Krishnaney AA; Kshettry VR; Moore NZ; Rasmussen PA; Bain MD J Neurosurg; 2024 Oct; 141(4):1138-1146. PubMed ID: 38701530 [TBL] [Abstract][Full Text] [Related]
18. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796 [TBL] [Abstract][Full Text] [Related]
19. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage. Ibeh C; Tirschwell DL; Mahr C; Creutzfeldt CJ J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106053. PubMed ID: 34418673 [TBL] [Abstract][Full Text] [Related]
20. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]